Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
US7635699B2 · kind B2 · utility
1Cited by
48References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2005 |
| Grant date | Dec 22, 2009 |
| Priority date | — |
| Expiry date | Nov 2, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided having the formula (I)wherein X for each occurrence is N or C-A, and R, Y, A and n are as defined herein, which compounds are dipeptidyl peptidase IV inhibitors and as such are useful in treating diabetes and micro- and macrovascular complications of diabetes, such as retinopathy, neuropathy, and nephropathy.A method for treating diabetes and related diseases employing the above compounds is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.